Cascinu S - Search Results

1

Cetuximab: still an option in the treatment of pancreatic cancer?

Faloppi L, Andrikou K, Cascinu S. Faloppi L, et al. Among authors: cascinu s. Expert Opin Biol Ther. 2013 May;13(5):791-801. doi: 10.1517/14712598.2013.786697. Expert Opin Biol Ther. 2013. PMID: 23560505 Review.

2

Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Cascinu S, Frontini L, Comella G, Barni S, Labianca R, Battelli N, Casaretti R, Zonato S, Pirovano M, Catalano G, Cellerino R. Cascinu S, et al. Br J Cancer. 1999 Feb;79(3-4):491-4. doi: 10.1038/sj.bjc.6690076. Br J Cancer. 1999. PMID: 10027318 Free PMC article. Clinical Trial.

3

Gastric cancer treatment: a systematic review.

Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Berardi R, et al. Among authors: cascinu s. Oncol Rep. 2004 Apr;11(4):911-6. Oncol Rep. 2004. PMID: 15010894 Review.

4

A cost-benefit analysis of chemotherapy for gastric cancer.

Galizia E, Berardi R, Scartozzi M, Cascinu S. Galizia E, et al. Among authors: cascinu s. Expert Opin Pharmacother. 2004 Oct;5(10):2109-14. doi: 10.1517/14656566.5.10.2109. Expert Opin Pharmacother. 2004. PMID: 15461546 Review.

5

Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice.

Scartozzi M, Pierantoni C, Berardi R, Squadroni M, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Expert Opin Ther Targets. 2006 Apr;10(2):281-7. doi: 10.1517/14728222.10.2.281. Expert Opin Ther Targets. 2006. PMID: 16548776 Review.

6

Epidermal growth factor receptor: a promising therapeutic target for colorectal cancer.

Scartozzi M, Pierantoni C, Berardi R, Antognoli S, Bearzi I, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Anal Quant Cytol Histol. 2006 Apr;28(2):61-8. Anal Quant Cytol Histol. 2006. PMID: 16637508 Review.

7

New target therapies in advanced pancreatic cancer.

Cascinu S, Verdecchia L, Valeri N, Berardi R, Scartozzi M. Cascinu S, et al. Ann Oncol. 2006 May;17 Suppl 5:v148-52. doi: 10.1093/annonc/mdj971. Ann Oncol. 2006. PMID: 16807445 Free article. Review.

8

Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancer.

Scartozzi M, Falcone A, Pucci F, Braconi C, Pierantoni C, Cavanna L, Franciosi V, Berardi R, Beretta G, Masi G, Allegrini G, Zaniboni A, Labianca R, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Tumori. 2006 Sep-Oct;92(5):384-8. doi: 10.1177/030089160609200503. Tumori. 2006. PMID: 17168429 Clinical Trial.

9

Chemotherapy for advanced gastric cancer: across the years for a standard of care.

Scartozzi M, Galizia E, Verdecchia L, Berardi R, Antognoli S, Chiorrini S, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. Expert Opin Pharmacother. 2007 Apr;8(6):797-808. doi: 10.1517/14656566.8.6.797. Expert Opin Pharmacother. 2007. PMID: 17425475 Review.

10

Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy.

Scartozzi M, Bearzi I, Pierantoni C, Mandolesi A, Loupakis F, Zaniboni A, Catalano V, Quadri A, Zorzi F, Berardi R, Biscotti T, Labianca R, Falcone A, Cascinu S. Scartozzi M, et al. Among authors: cascinu s. J Clin Oncol. 2007 Sep 1;25(25):3930-5. doi: 10.1200/JCO.2007.11.5022. J Clin Oncol. 2007. PMID: 17761976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

650 results

Search Page